KEGG   DRUG: Bulevirtide acetate
Entry
D11878                      Drug                                   

Name
Bulevirtide acetate;
Hepcludex (TN)
Remark
ATC code: J05AX28
Chemical structure group: DG03116
Efficacy
Antiviral, Entry inhibitor
  Disease
Hepatitis delta virus infection [DS:H00414]
Target
HDV antigen
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AX Other antivirals
     J05AX28 Bulevirtide
      D11878  Bulevirtide acetate
Antiinfectives [BR:br08307]
 Antivirals
  Entry, fusion or uncoating inhibitor
   Hepatitis virus antigen
    D11878  Bulevirtide acetate
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D11878
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D11878
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system